Adapting imaging protocols for PET-CT and PET-MRI for immunotherapy monitoring
Hybrid imaging with positron emission tomography (PET) in combination with computer tomography (CT) is a well-established diagnostic tool in oncological staging and restaging. The combination of PET with magnetic resonance imaging (MRI) as a clinical scanner was introduced approximately 10 years ago...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 November 2021
|
| In: |
Cancers
Year: 2021, Jahrgang: 13, Heft: 23, Pages: 1-9 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers13236019 |
| Online-Zugang: | kostenfrei kostenfrei 
|
| Verfasserangaben: | Bettina Beuthien-Baumann, Christos Sachpekidis, Regula Gnirs and Oliver Sedlaczek |
| Zusammenfassung: | Hybrid imaging with positron emission tomography (PET) in combination with computer tomography (CT) is a well-established diagnostic tool in oncological staging and restaging. The combination of PET with magnetic resonance imaging (MRI) as a clinical scanner was introduced approximately 10 years ago. Although MRI provides superb soft tissue contrast and functional information without the radiation exposure of CT, PET-MRI is not as widely introduced in oncologic imaging as PET-CT. One reason for this hesitancy lies in the relatively long acquisition times for a PET-MRI scan, if the full diagnostic potential of MRI is exploited. In this review, we discuss the possible advantages of combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single patient visit. |
|---|---|
| Beschreibung: | Gesehen am 08.06.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers13236019 |